Note: The Global Autoimmune Institute team is unable to provide medical advice on COVID-19, vaccines, autoimmune disease, or other health concerns. For more information on coronavirus, please visit the CDC, NIH, NHS, or your country’s public health agency.
Researchers around the world are creating and testing over 100 vaccines in an effort to combat the novel coronavirus. This chart breaks down the leading vaccines that have shown promise through pre-clinical data, completed Phase 1/2/3 clinical trials, and have been authorized for emergency use/ received approval.
The increasingly prevalent illness that follows COVID-19 goes by several names, including long COVID. There is much that remains unknown about long COVID, but many experts propose that studies called Long COVID Surveys are vital to understanding and addressing this emerging health crisis.
Read More »
Over the course of the pandemic, Global Autoimmune Institute has stayed abreast of research on the novel coronavirus and its impact on those living with autoimmune disease.
Read More »
Retrospective hospital analyses and cohort studies have shown that people with autoimmune disease are not more susceptible to severe COVID-19 symptoms.
Read More »